Akademisyen
HAVVA YAZICI
DOKTOR ÖĞRETİM ÜYESİ (Unvan:Doçent)
EGE ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Çocuk Metabolizma Hastalıkları (Çocuk Sağlığı ve Hastalıkları)
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 95
- Proje 0
- Kitap 7
- Bildiri 151
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
25
Q2
23
Q3
30
Q4
3
WoS (JCR)
Q1
17
Q2
14
Q3
21
Q4
23
TR Index
37
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
6
Ort. yüzdelik
51.1%
Üst %1 payı
0.0%
Üst %10 payı
6.6%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 Real-World Experience from Türkiye: Genetic and Therapeutic Insights in Pediatric Heterozygous Familial Hypercholesterolemia YÖKSİS TR Index SJR Q2 JCR Q2 OpenAlex 30.4%
- 2026 Distinct Brain Magnetic Resonance Imaging (MRI) Findings Across Mucopolysaccharidosis Types: Novel Insights YÖKSİS SJR Q2 JCR Q3 OpenAlex 18.8%
- 2025 DHCR24-related desmosterolosis in the first reported Turkish patient: Expanding the genotypic and phenotypic spectrum YÖKSİS SJR Q1 JCR Q1 OpenAlex 43.8%
- 2025 The effect of triheptanoin treatment on clinical and laboratory outcomes in patients with long-chain fatty acid oxidation disorder. YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 90.0%
- 2025 Long-Term Outcomes of Chenodeoxycholic Acid Therapy for Cerebrotendinous Xanthomatosis: A Nationwide Study on Prognostic Factors and Treatment Response YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 95.8%
- 2025 Nutritional management and geno-phenotyping of clinical nutrition in patients with glycogen storage diseases type VI and IX YÖKSİS SJR Q1 JCR Q2 OpenAlex 70.0%
- 2025 Glutaric aciduria type 1: Insights into diagnosis and neurogenetic outcomes YÖKSİS SJR Q1 JCR Q1 OpenAlex 67.7%
- 2025 Genotype–Phenotype Correlations and Shifting Diagnosis Age in Turkish Mucopolysaccharidosis Type II Patients: A Multicenter Retrospective Study YÖKSİS SJR Q2 JCR Q1 OpenAlex 30.9%
- 2025 Insights into skeletal involvement in adult Gaucher disease: a single-center experience YÖKSİS SJR Q2 JCR Q3 OpenAlex 61.9%
- 2025 Simultaneous Determination of Lyso-Gb1 and Lyso-Gb3 in Plasma Using Salt-Assisted Liquid–Liquid Extraction Combined with LC–MS/MS YÖKSİS SJR Q1 JCR Q2 OpenAlex 37.3%
- 2025 Mucolipidosis type II and III: clinical spectrum, genetic landscape, and longitudinal outcomes in a pediatric cohort with six novel mutations YÖKSİS SJR Q3 JCR Q3 OpenAlex 80.9%
- 2025 Cardiac involvement as a gateway to the diagnosis of inherited metabolic disorders: A 16-year pediatric experience from a tertiary metabolic center YÖKSİS TR Index OpenAlex 23.8%
- 2025 Effect of large neutral amino acids treatment on blood phenylalanine, tyrosine, and tryptophan levels in adolescent and young adult PKU patients YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 15.1%
- 2025 EVALUATION OF EXPERIENCED CLINICAL EVENTS IN POMPE DISEASE BASED ON REAL-LIFE DATA YÖKSİS SJR Q2 JCR Q3 OpenAlex 55.1%
- 2025 Severe Hypercholesterolemia in a Pediatric Cohort: Familial Homozygous and Autosomal Recessive Hypercholesterolemia YÖKSİS SJR Q1 JCR Q1 OpenAlex 47.5%
- 2025 Genetic Landscape of Pediatric Dyslipidemia in a Turkish Cohort: Insights From a Single‐Center Experience YÖKSİS SJR Q3 JCR Q4 OpenAlex 37.9%
- 2025 A retrospective study on neuropsychiatric presentations of mucopolysaccharidoses YÖKSİS TR Index OpenAlex 23.3%
- 2024 Determination of selected oxysterol levels, oxidative stress, and macrophage activation indicators in children and adolescents with familial hypercholesterolemia YÖKSİS SJR Q1 JCR Q1 OpenAlex 89.9%
- 2024 Long‐term personalized high‐protein, high‐fat diet in pediatric patients with glycogen storage disease type IIIa: Evaluation of myopathy, metabolic control, physical activity, growth, and dietary compliance YÖKSİS SJR Q1 JCR Q2 OpenAlex 85.1%
- 2024 Factors affecting quality of life and hopelessness levels of patients with intravitreal injection YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 33.2%